The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 08, 2022

Filed:

Aug. 28, 2019
Applicant:

Actym Therapeutics, Inc., Berkeley, CA (US);

Inventors:

Christopher D. Thanos, Tiburon, CA (US);

Laura Hix Glickman, Oakland, CA (US);

Assignee:

Actym Therapeutics, Inc., Berkeley, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); C07K 16/40 (2006.01); A61K 35/74 (2015.01); A61K 35/768 (2015.01); C12N 7/00 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 35/74 (2013.01); A61K 35/768 (2013.01); A61K 47/6873 (2017.08); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 16/40 (2013.01); C12N 7/00 (2013.01); C07K 2317/76 (2013.01); C12N 2310/122 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12N 2710/16633 (2013.01); C12N 2710/24133 (2013.01); C12N 2720/12033 (2013.01); C12N 2760/18433 (2013.01);
Abstract

Provided are immunostimulatory bacteria and oncolytic viruses, and pharmaceutical compositions containing the bacteria and/or viruses, that act as three prime repair exonuclease 1 (TREX1) antagonists. The bacteria and viruses are for treating tumors that are human papillomavirus (HPV) positive or that have a high tumor mutational burden (TMB). The immunostimulatory bacteria and oncolytic viruses encode therapeutic products such RNAi, such as shRNA and microRNA, that mediate gene disruption and/or inhibit expression of TREX1, or that inhibit TREX1. The bacteria contain additional modifications to enhance their anti-tumor activity. The bacteria and viruses are used for treatment of tumors in which TREX1 expression correlates with the presence of the tumor or properties of the tumor, such that inhibition of TREX1 advantageously treats the tumor.


Find Patent Forward Citations

Loading…